IQEIQE plc

IQE has performed well with institutional validation.

Point 72 and other institutions are buying at all-time highs, indicating a fundamentally sound thesis for $AXTI and $IQE.

Revisiting original thesis: IQE could 10x to $1B+ by refocusing on photonics and completing asset sales to clean up balance sheet, compared to landmark (LAND) at $3.8B with less reactor capacity.

Point72 and other institutions are buying up the float of IQE at all-time highs, causing the stock to go parabolic.

European frontier companies like IQE, SIVE, ALRIB, SOI, and RPI are undervalued national security gems, with strong YTD performance, but local investors sell at the bottom while American investors benefit. The companies have potential for scaling production for US hyperscalers.

Expects critical chokepoint supply chain companies to compound triple digits as institutional capital pours in, especially $SIVE after Nasdaq listing.

Reaffirms long-term bullish thesis on a basket of semiconductor and related stocks, noting that short-term entry points vary but overall market validation continues.

IQE is at the beginning of institutional discovery stage, with Point72 buying last week. Despite already being up a few hundred percent, it is still early.

AI hyperscaler demand is causing widespread supply chain bottlenecks across semiconductors, materials, and infrastructure components, benefiting companies exposed to CPUs, semiconductor equipment, photoresists, grid components, optical modules, and photonics.

IQE is a structural chokepoint in the photonics supply chain, and MTSI's $45M investment with board seat validates this while securing long-term epiwafer supply.

MTSI taking IQE out of debt and becoming a strategic investor is incredibly positive for IQE.

MTSI plans to invest $45M into IQE, buy them out of debt, and become a strategic investor, which is a positive development for IQE as it addresses financial overhang and validates IQE's strategic position.

Institutions are accumulating silicon photonics plays ($SOI, $IQE) as structural chokepoints in AI, validating the user's earlier thesis.

IQE's arrangement with MTSI to pay off debts is fundamentally different from SLNH's dilutive ATM, implying a stronger financial position for IQE.

Buy these stocks at the bottom for full supercycle exposure as markets are forward-looking and will price in future scaling from 2026 to 2028.

Post presents bullish theses on four photonics/advanced packaging plays: SIVE (CW laser supplier, expected to become next LITE), LPK (glass substrates, pure exposure, upcoming volume ramp), AAOI (largest US photonics supply chain, 1.6T wave), IQE (critical epiwafer supplier, bottlenecked, undervalued). All are long-term holds due to the photonics supercycle and AI scaling.

Export controls on Rasa/NCI to halt China's InP substrate production would cause collateral damage to IQE and LITE, while controls on Ulvac and other chokepoints for humanoid production have less collateral harm.

European photonics companies SIVE, IQE, and SOI are core players hitting double digit recoveries; dips are likely to be bought out.

AI capex growth to $3-$4 trillion annually by 2030 will benefit companies controlling key AI buildout components: photonics, silicon photonics, laser chokepoints, epiwafer supply chains, neoclouds, and memory.

Expecting IQE to triple or more, but disappointed with current performance; still holding hope.